Diffuse Liver Fibrosis: When to Seek Further Evaluation - Gastroenterology and Hepatology

Share to:

"Diffuse" liver fibrosis


Dear Dr.
Li,
Hello! My mother is 82 years old and had breast cancer surgery five years ago (without chemotherapy).
She has diabetes, hypertension, and hyperlipidemia.
She has been tested negative for hepatitis B, but has not been tested for hepatitis A or C.
A few years ago, she experienced abnormal liver function and took liver medication prescribed by Chiayi Saint Martin Hospital for over a year until her liver function returned to normal (ultrasounds have been normal each time).
Since it has been normal, she has not had any checks for over a year.
Recently, she went to a nearby clinic for a check-up, and the results showed slightly elevated liver function.
The ultrasound appeared hazy, and the doctor mentioned it could be liver fibrosis, but did not definitively rule out liver cancer.
When I asked if we should seek a CT scan at a larger hospital, the doctor suggested just to observe and check again in three months.
The doctor also mentioned that given my mother's age and health, even if something serious is found, she may not be able to tolerate further treatment.
I am not convinced and sought a second opinion at another clinic, which also noted a hazy area, possibly indicating diffuse liver fibrosis, but likely not liver cancer, as liver cancer typically does not present bilaterally.
They also recommended just to observe for three months.
Neither clinic prescribed any medication, leaving me uncertain about what to do.
It seems somewhat serious, yet it also feels like it might not be.
Should we go to a larger hospital for further examination, or is it acceptable to just observe for three months? I would appreciate your insights.
Thank you!

yoyo, 50~59 year old female. Ask Date: 2011/10/08

Dr. Li Yongming reply Gastroenterology and Hepatology


Reply: Hello, regarding hepatitis, in Taiwan, chronic hepatitis B and C are still the most prevalent, particularly in the Chiayi and Tainan regions.
When liver enzymes (AST/ALT) are elevated, it is essential to test for HBsAg (Hepatitis B Surface Antigen) and anti-HCV Ab (Hepatitis C Antibody) as preliminary screenings for viral hepatitis.
However, under the current health insurance review system, if HBsAg or anti-HCV Ab is tested without cause, it may be disallowed.
Therefore, please bring your mother's abnormal liver enzyme report to a hepatobiliary specialist for further evaluation.
Currently, the consensus among health insurance reviewers is that for patients with chronic hepatitis B or C, if liver enzymes (AST/ALT) are elevated, liver protectants can be prescribed; however, for hepatitis caused by other reasons, liver enzymes must exceed twice the normal value to qualify for prescription.
Under the intensified scrutiny of health insurance, medications cannot be prescribed if they do not meet the criteria.
Some medical studies indicate that certain liver protectants may reduce liver enzyme levels, but this only addresses the symptoms and does not treat the underlying cause.
Whether or not one is taking liver protectants is not clinically significant.
As for liver fibrosis, it is understood that it results from the liver undergoing chronic inflammation, leading to regenerative tissue formation.
When liver inflammation is severe and exceeds its repair capacity, fibrous tissue is formed to provide support, resulting in a loss of normal elasticity, making the liver feel hard like a stone.
Over time, this can lead to cirrhosis.
The gold standard for diagnosis is a liver biopsy, with the final determination made by a pathologist.
Clinically, ultrasound is used as an initial screening tool.

Reply Date: 2011/10/08

More Info


When it comes to diffuse liver fibrosis, especially in elderly patients with a history of other health issues, it is crucial to approach the situation with a comprehensive understanding of the underlying conditions and the implications of the findings. In your mother’s case, the presence of a "hazy" appearance on ultrasound and slightly elevated liver function tests could indeed suggest some degree of liver fibrosis. However, it is essential to differentiate between various potential causes of liver abnormalities, including fatty liver disease, chronic hepatitis, or even the effects of her other medical conditions such as diabetes and hypertension.

Firstly, the term "coarse echo pattern" observed in ultrasound imaging can indicate changes in liver architecture, which may correlate with fibrosis. However, it is important to note that ultrasound is not definitive for diagnosing fibrosis. While it can suggest the presence of fibrosis, it cannot quantify its severity accurately. For a more precise assessment, non-invasive methods such as FibroScan or even a liver biopsy may be warranted, especially if there is a concern about the progression of liver disease.

Given your mother's age and medical history, including her previous breast cancer and current chronic conditions, the decision to pursue further evaluation should be carefully weighed. If her liver function tests are only slightly elevated and she is asymptomatic, the recommendation to monitor her condition for a few months may be reasonable. However, if there are any concerning symptoms—such as jaundice, significant abdominal pain, or changes in mental status—immediate evaluation would be necessary.

In terms of follow-up, it is generally advisable to have regular monitoring of liver function tests and imaging studies, especially in patients with risk factors for liver disease. If the follow-up ultrasound continues to show abnormalities or if liver function tests worsen, further evaluation should be considered. This could include more advanced imaging techniques like a CT scan or MRI, which can provide more detailed information about liver structure and any potential lesions.

Moreover, it is essential to consider the overall health status of your mother. If she is stable and her other chronic conditions are well-managed, the risk of significant liver disease may be lower. However, if there are any doubts or if you feel uncomfortable with the current management plan, seeking a second opinion from a hepatologist or a liver specialist at a larger medical center could provide additional insights and reassurance.

In conclusion, while the current approach of monitoring may be appropriate given the circumstances, it is crucial to remain vigilant. If there are any changes in her health status or if you have ongoing concerns, do not hesitate to advocate for further evaluation. Early detection and management of liver disease can significantly impact outcomes, especially in patients with complex medical histories.

Similar Q&A

Understanding Mild Liver Fibrosis: Should You Seek Further Evaluation?

I would like to ask the doctor about the abdominal ultrasound examination during a health check-up, which revealed mild hepatic parenchymal fibrosis, but liver function tests are normal. Should I go for a follow-up outpatient examination? Is fibrosis reversible? Thank you, doctor...


Dr. Lin Minghui reply Gastroenterology and Hepatology
Regarding liver parenchymal lesions, follow-up is recommended. Is liver fibrosis reversible? Identifying the cause of fibrosis is essential for targeted treatment. Conditions such as viral hepatitis (hepatitis B, C, D), alcoholic or metabolic liver disease, autoimmune hepatitis, ...

[Read More] Understanding Mild Liver Fibrosis: Should You Seek Further Evaluation?


Understanding Diffuse Liver Disease: Prevention and Treatment Insights

What is diffuse liver disease? How can it be prevented and treated? Please explain, Dr. Yang. Thank you!


Dr. Yang Guojun reply Gastroenterology and Hepatology
Diffuse liver disease should first be diagnosed through ultrasound or blood tests. If the diagnosis is made via ultrasound, further testing for hepatitis B and C infections should be conducted. If neither of these viruses is present and there is no history of alcohol consumption,...

[Read More] Understanding Diffuse Liver Disease: Prevention and Treatment Insights


Understanding Liver Fibrosis: Concerns, Treatment, and Next Steps

Hello, doctor: Recently, my mother was diagnosed with liver fibrosis at the hospital. However, we are still waiting for the blood test results to evaluate further. A few days later, when my mother returned for a follow-up, the doctor told her that since it is only a little bit, t...


Dr. Chen Qifeng reply Gastroenterology and Hepatology
Hello, to address liver fibrosis, it is essential to identify the underlying cause in order to provide appropriate treatment. Currently, there are no medications that can immediately improve fibrosis. Common causes include chronic hepatitis B, hepatitis C, autoimmune liver diseas...

[Read More] Understanding Liver Fibrosis: Concerns, Treatment, and Next Steps


Understanding Early Cirrhosis: Autoimmune Liver Disease Insights and Management

Hello Doctor, two years ago during a health check-up, fetal alpha-fetoprotein was found to be 13.8, and both GOT and GPT levels were elevated. An ultrasound indicated that the liver appeared enlarged, suggesting liver fibrosis. Blood tests ruled out hepatitis B and alcohol consum...


Dr. Chen Shidian reply Gastroenterology and Hepatology
Your situation is quite unique; there is significant individual variation in autoimmune hepatitis, and medication regimens can differ accordingly. Therefore, it is essential to tailor the treatment to your specific condition. Please discuss this further with your attending physic...

[Read More] Understanding Early Cirrhosis: Autoimmune Liver Disease Insights and Management


Related FAQ

Liver Fibrosis

(Gastroenterology and Hepatology)

Liver Cirrhosis

(Gastroenterology and Hepatology)

Jaundice

(Gastroenterology and Hepatology)

Gastroesophageal Reflux Disease

(Gastroenterology and Hepatology)

Hepatitis C

(Gastroenterology and Hepatology)

Fatty Liver

(Gastroenterology and Hepatology)

Cholecystitis

(Gastroenterology and Hepatology)

Liver Nodules

(Gastroenterology and Hepatology)

Liver Cancer

(Gastroenterology and Hepatology)

Health Check-Up Report

(Gastroenterology and Hepatology)